Moleculin Biotech Return on Net Operating Assets Analysis

Moleculin Biotech, Inc. (MBRX)

3.32 -0.12 (-3.49%) USD | NASDAQ | Dec 30, 16:00

3.28 -0.04 (-1.20%) After-Hours: 20:00

View Return on Net Operating Assets for MBRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	Upgrade
Harvard Bioscience, Inc.	Upgrade
Intensity Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade

Upgrade